LGBT Cancer Project

Renal Cell Cancer Clinical Trials

A listing of Renal Cell Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Daphne Alabama 36526

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Mobile Alabama 36608

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Mobile Alabama 36607

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

California

UPDATED

Beverly Hills California 90211

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Los Angeles California 90048

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Los Angeles California 90048

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Colorado

UPDATED

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

District of Columbia

UPDATED

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Florida

UPDATED

Tampa Florida 33612

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Tampa Florida 33612

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Georgia

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Iowa

Louisiana

UPDATED

Metairie Louisiana 70006

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Metairie Louisiana 70006

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Metairie Louisiana 70006

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Maine

UPDATED

Brunswick Maine 04011

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Kennebunk Maine 04043

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Scarborough Maine 04074

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Maryland

UPDATED

Baltimore Maryland 21231

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Baltimore Maryland 21231

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Massachusetts

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Minnesota

UPDATED

Rochester Minnesota 55905

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Missouri

UPDATED

Creve Coeur Missouri 63141

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

St. Louis Missouri 63129

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

St. Peters Missouri 63376

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Montana

UPDATED

Billings Montana 59101

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Billings Montana 59102

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Nevada

UPDATED

Las Vegas Nevada 89148

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Las Vegas Nevada 89169

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

New York

UPDATED

Albany New York 12206

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer